Iris Syn AS
Not financial advice. The index, rank, signals and advice are rule-based indications from the latest filed annual accounts. They are not a credit rating, an assessment of management or a recommendation to buy, sell or do business with the company. Read more
Key facts
Is the company run well?
Five key figures against companies in the Morning class Micro in the same sector. Green is better than most, amber about like the industry and red weaker than most.
- Profitability · operating margin 32.6% Better than the industry Industry: 8.9%
- Returns · return on assets 31.1% Better than the industry Industry: 18.9%
- Solidity · equity ratio 1.9% Weaker than the industry Industry: 43.5%
- Liquidity · current ratio 0.61 Weaker than the industry Industry: 1.56
The mark comes from the company's place among comparable companies (percentile): green from 60, amber from 40, red below 40. Negative equity, an operating loss and a current ratio under 1 pull it down regardless. Methodology
Score · fiscal year 2025
44of 100
How to read this: the company is ahead of 38 % of companies in the Morning class Micro in the same sector in 2025. What does this mean?
Rank in the Morning class Micro: 3,438 of 5,524 · What are Morning company classes?
Place in the whole sector: 4,134 of 6,597 · Helse og omsorg
Profile
Cheetah · Sprinter
High profitability, lower resilience
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 73 and resilience 11 out of 100 among companies in the Morning class Micro in the same sector in 2025. Methodology
Against the sector
Iris Syn AS is 7 points below the median for companies in the Morning class Micro in the same sector in 2025.
Median score 51 among 5,516 companies.
Against companies in the Morning class Micro in the same sector in 2025: operating margin 32.6% (median 8.9%) and equity ratio 1.9% (median 43.5%).
Where it stands · 2025
We only have the accounts for 2025. The development shows once we have at least two years.
Amounts in the reporting currency. The full year-by-year table is further down under «Details». See every figure year by year
Accounts in short
| Key figure | 2025 |
|---|---|
| Operating revenue | 1.5 MNOK |
| Operating profit | 0.5 MNOK |
| Net profit | 0.4 MNOK |
| Total assets | 1.6 MNOK |
| Equity | 0.0 MNOK |
| Total liabilities | 1.6 MNOK |
From the Brønnøysund Register Centre, in the company's reporting currency (NOK). See every figure year by year
From the Central Coordinating Register
- Org. no.
- 935864399
- Legal form
- AS
- Sector
- Helse og omsorg (86.221)
- Purpose
- Selge tjenester og varer innen øyemedisin og annet som naturlig sammenfaller med dette.Investeringer og nærliggende virksomhet samt deltakelse i andre selskap.
- Morning company class
- Micro
- Employees
- 0–4 (not registered) Payroll costs in the accounts: 0.1 MNOK (2025).
- Founded
- 3 July 2025 1 years in operation
- Share capital
- 0.03 MNOK
- Business address
- Ole Vigs gate 7B, 1517 MOSS
- Municipality
- Moss rank 4–9 of 10 in KOSTRA group 11
- Audit
- Audit opted out from 18 July 2025
- Latest accounts filed
- 2025
- VAT registered
- No
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Iris Syn AS has a score of 44 for 2025, rank 4,134 of 6,597 in the sector.
Strongest: Profitability: percentile 73 against peers, operating margin 32.6% against a median of 8.9%.
Weakest: Solidity: percentile 8 against peers, equity ratio 1.9% against a median of 43.5%. Liquidity: percentile 9 against peers, current ratio 0.61 against a median of 1.56.
Worth a closer look
- The equity ratio is very low. Could the company absorb a bad year, and does it need more equity? Based on: equity ratio 1.9% (median 43.5%).
- Consider strengthening liquidity: current liabilities are 1.6 times current assets. Based on: current ratio 0.61 (median 1.56).
- Current liabilities exceed current assets other than bank deposits, and the current ratio is weak. Is it customer prepayments and supplier credit that fund the operations, or short-term loans that must be renewed? Based on: net working capital to revenue −101.5% (median −9.6%); current ratio 0.61 (median 1.56).
- What lies behind weak solidity, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
Worth a closer look
- watch
The equity ratio is very low. Could the company absorb a bad year, and does it need more equity?
Based on: Equity ratio 1.9% (median 43.5%).
- watch
Consider strengthening liquidity: current liabilities are 1.6 times current assets.
Based on: Current ratio 0.61 (median 1.56).
- watch
Current liabilities exceed current assets other than bank deposits, and the current ratio is weak. Is it customer prepayments and supplier credit that fund the operations, or short-term loans that must be renewed?
Based on: Net working capital to revenue −101.5% (median −9.6%); Current ratio 0.61 (median 1.56).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.0% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 8 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 73 | weight 40% |
|---|---|---|
| Solidity | 8 | weight 20% |
| Liquidity | 9 | weight 5% |
| Growth | – | no data, left out |
| Consistency | 20 | weight 10% |
Three goals: profitability 40%, growth 25%, resilience 35%. Why these weights?
Index version 3. Data completeness 75%: the share of the weights that had data.
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 2 MNOK | 3 MNOK |
| Operating margin | 32.6% | 8.9% |
| Profit margin | 32.6% | 9.1% |
| Return on assets | 31.1% | 18.9% |
| Equity ratio | 1.9% | 43.5% |
| Debt-to-equity | 51.82 | 0.99 |
| Current ratio | 0.61 | 1.56 |
| Revenue growth | – | 4.1% |
The median and “ahead of” refer to companies in the Morning class Micro in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 44, Iris Syn AS does better than 38% of companies in the Morning class Micro in the same sector (5,524 companies) in 2025.
Score over time
Score over time needs at least two fiscal years with a score. It will appear when next year's figures are fetched or history is imported.
Working capital and debt
| Measure | Company | Median | |
|---|---|---|---|
| Working capital | |||
| Receivable days All current receivables, including those on group companies, in days of revenue. |
0 days | 14 days | |
| Inventory and other current assets, days Current assets other than receivables and bank deposits, that is inventory and short-term investments, in days of revenue. |
0 days | 0 days | |
| Net working capital to revenue Current assets less bank deposits less current liabilities, divided by revenue. Negative: short-term debt funds the operations. |
−101.5% | −9.6% | |
| Cash share of current assets How much of the short-term buffer is bank deposits and cash. |
99.7% | 75.9% | |
| Debt and interest burden | |||
| Interest coverage (times) Operating result divided by all financial costs. Below 1: operations do not cover the cost of the debt. |
– | 38.0 | |
| Financial costs as a share of debt All financial costs (interest, currency losses and other) divided by all debt, interest-free debt included. Not an interest rate. |
0.0% | 0.3% | |
| Long-term share of debt Long-term debt as a share of all debt. A low share means more falls due within a year. |
– | 6.4% | |
Net working capital (current assets less bank deposits less current liabilities): −1.5 MNOK.
The median and the bar refer to companies in the Morning class Micro in the same sector in 2025. The bar shows the share of the group with a lower figure: higher is not always better, long receivable days tie up capital, for example. These figures do not count in the score.
Returns, debt against earnings and quality
| Measure | Company | Median | |
|---|---|---|---|
| Returns | |||
| Return on equity (ROE) Net result over the average of equity at the start and end of the year (the end alone when last year is missing). Not calculated with negative equity. |
1,285.1% | 30.0% | |
| Return on capital employed (ROCE) Operating result over capital employed, that is total assets less current liabilities. The return regardless of how the company is financed. |
988.8% | 28.2% | |
| Net margin Net result over revenue. The first part of the DuPont split of return on equity. |
25.5% | 7.4% | |
| Asset turnover (revenue over assets) Revenue over total assets: how many kroner of revenue each krone of assets gives. The second part of the DuPont split. |
0.95 | 2.14 | |
| Equity multiplier Total assets over equity: 4 means three quarters is financed with debt. The third part of the DuPont split. |
52.82 | 1.99 | |
| Debt and financing | |||
| Net debt in times operating result Long-term liabilities less cash, over the operating result: roughly how many years the business must earn to repay the debt. A negative figure means more cash than long-term debt. Rough, because the accounts do not split out interest-bearing debt. Only calculated when the operating result is positive. |
– | −1.0 | |
| Fixed-asset cover Equity plus long-term liabilities over fixed assets (total assets less current assets). Below 1: fixed assets are partly financed with short-term debt. |
– | 1.65 | |
| Quick ratio (without inventory) Cash plus receivables over current liabilities. Like the current ratio but without inventory and short-term investments. |
0.61 | 1.38 | |
| Quality and resilience | |||
| Effective tax rate Tax expense over profit before tax, only when the profit is positive. Far from 22% points to one-off items, tax losses carried forward or group contributions. |
21.7% | 22.0% | |
| Operating leverage Percentage change in operating result over percentage change in revenue from last year. 3 means a 1% fall in revenue gives a 3% fall in operating result. Only calculated when revenue moved at least 2% and last year's operating result was positive. |
– | 1.8 | |
| Payroll costs over revenue Payroll costs (with employer's contribution and pension) over revenue. Shows how much of revenue is a fixed cost in a service business. |
5.6% | 45.5% | |
| Revenue safety margin How far revenue can fall before the operating result is zero, assuming payroll is fixed and all other costs follow revenue. A calculation, not a measurement: depreciation and rent are also fixed, so reality is lower. |
85.4% | 27.0% | |
| Cash runway (months) Cash over the operating loss per month, only for years with a loss. Assumes the loss continues unchanged and no new financing arrives. Capped at 120 months. |
– | 32 mo. | |
DuPont on the closing balance: net margin 25.5% × asset turnover 0.95 × multiplier 52.82 = 1,285.1% of equity at the end of the year. The return on equity above uses average equity and can differ slightly.
The median and the bar are for companies in the Morning class Micro in the same sector in 2025. The bar shows the share of the group with a lower figure: high is not always good. The figures are our own calculations from the annual accounts and do not count in the score. Open data has no depreciation, so no EBITDA, and the accounts do not split out interest-bearing debt. How we calculate
The industry or the company: what drove the result?
The company and its sector's drivers
Prices, rate and currency that shape the sector's year, year by year beside the operating margin of Iris Syn AS. The figures stand side by side; we claim no cause.
Consumer price index (indeks (2025 = 100))
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Consumer price index, annual average | 84.3 | 89.2 | 94.1 | 97.0 | 100.0 | 103.0 (so far) |
| Change from the year before | +3.5% | +5.8% | +5.5% | +3.2% | +3.0% | +3.0% |
| The company's operating margin | – | – | – | – | 32.6% | – |
Source: SSB (14710, CC BY 4.0). Source
Policy rate (prosent)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Policy rate, annual average | 0.08 | 1.32 | 3.54 | 4.50 | 4.30 | 4.17 (so far) |
| Change from the year before | −0.28 percentage points | +1.24 percentage points | +2.22 percentage points | +0.96 percentage points | −0.20 percentage points | −0.12 percentage points |
| The company's operating margin | – | – | – | – | 32.6% | – |
Source: Norges Bank (IR, NLOD 2.0). Source
Wage index: health services (indeks)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Wage index: health services, annual average | 88.0 | 91.6 | 96.0 | 100.6 | 105.8 | 109.5 (so far) |
| Change from the year before | +2.5% | +4.1% | +4.7% | +4.9% | +5.1% | +3.6% |
| The company's operating margin | – | – | – | – | 32.6% | – |
Source: SSB (12314, CC BY 4.0). Source
We show the drivers and the margin side by side and claim no cause. Sensitivity per company is not computed until we have at least 10 years of accounts per company: with three years such figures are false precision.
What the numbers say
Iris Syn AS had an operating margin of 32.6% and an equity ratio of 1.9% in 2025, and ranks 4,134 of 6,597 in Helse og omsorg.
This text is generated automatically from the 2025 accounts.
Three simple methods
Suggested price: about 4 MNOK
The mean of the 3 methods below (P/E, EV/EBIT and P/B with listed multiples and a size adjustment), rounded to two significant figures. It is a calculation, not a bid or a valuation. The methods differ widely (the highest is 395.3 times the lowest), so the estimate is uncertain.
That is about 140 NOK per share, on 30,000 shares in the shareholder register.
The methods give between 0 MNOK and 8 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 18.8 | 4 MNOK |
| EV/EBIT | 23.4 | 8 MNOK |
| P/B | 1.1 | 0 MNOK |
| EV/EBIT: from enterprise value to equity | NOK |
|---|---|
| Enterprise value (EV) at the listed multiple | 12 MNOK |
| Enterprise value after the size adjustment | 7 MNOK |
| Less net debt (rough figure) | −1 MNOK |
| Equity value | 8 MNOK |
Net debt is a rough figure: long-term liabilities minus cash. The accounts do not split interest-bearing debt from other liabilities, and short-term borrowings are not included. The size adjustment applies to the enterprise value, not to the debt.
The listed basis is the value at listed multiples. The estimate is lowered for size: a small-company premium of 4% on the cost of equity gives a value 38% lower. No separate marketability discount is applied, because the premium already allows for the company being small and unlisted.
The multiples are from the listed industry that matches the NACE code (86): Hospitals/Healthcare Facilities.
Not financial advice. The value range is a rough model estimate from listed-company multiples, not a valuation, a price target or a price offer. The actual value may differ greatly. Read more
A mechanical estimate from public accounts, not advice. A mechanical estimate from public accounts with listed multiples and fixed adjustments. Not a valuation and not advice to buy or sell. See the calculation
Figures you will not find in any register
We calculated these figures ourselves from the accounts and registers we have read. The company has not reported them and the Brønnøysund Register Centre does not publish them. They are indications and are not part of the index. How we calculate
- Owners and leadership aged 60 or older
- No sign of a near generation change in the ages.
- The chair is under 60.
- The managing director is under 60.
- 0 of 1 on the board are 60 or older.
Not financial advice. The index, rank, signals and advice are rule-based indications from the latest filed annual accounts. They are not a credit rating, an assessment of management or a recommendation to buy, sell or do business with the company. Read more
Questions and answers
How profitable is Iris Syn AS?
The operating margin was 32.6% in 2025, against a median of 8.9% among companies in the Morning class Micro in the same sector. Return on assets was 31.1%.
How solid is Iris Syn AS?
The equity ratio was 1.9% in 2025 (median 43.5%). Debt-to-equity was 51.82 (median 0.99).
What is the liquidity of Iris Syn AS like?
The current ratio was 0.61 in 2025 (median 1.56). Current assets did not cover current liabilities.
How does Iris Syn AS compare in Helse og omsorg?
Iris Syn AS ranks 4,134 of 6,597 in Helse og omsorg for 2025. Among companies in the Morning class Micro it is number 3,438 of 5,524.
Competitors
The 8 closest competitors in the same line of business, placed in the same matrix as the sector page: profitability up, resilience to the right. These are the companies the competitor analysis and the strategy report compare with.
Each bubble is a company: this company and its closest competitors in the same line of business and size, the same ones the competitor analysis uses. Placement is 0–100 against the whole sector and Morning company class: further right is more robust, higher up is more profitable. Bubble size is revenue. The light bubble and arrow show where the company stood the year before. Pick a profile to see fewer at a time.
| Company | Profile | Operating revenue | Operating margin | Score |
|---|---|---|---|---|
| Vitalux Helse AS |  Beaver |
2 MNOK | 3.9% | 41 |
| Husbyklinikkene AS | Beaver |
2 MNOK | −23.9% | 3 |
| Rådhuset Spesialistsenter AS | Beaver |
2 MNOK | −0.2% | 31 |
| Iris Syn AS (this company) |  Cheetah |
2 MNOK | 32.6% | 44 |
| Sam Enayati Consulting AS | Cheetah |
2 MNOK | 77.1% | 64 |
| Johannessen Kompetanse AS |  Lion |
2 MNOK | 58.1% | 69 |
| Dermalog AS | Lion |
1 MNOK | 74.6% | 71 |
| Gynekolog S Ehrig AS |  Elephant |
1 MNOK | 7.4% | 48 |
| Sport Medicine Science AS | Lion |
1 MNOK | 48.6% | 55 |
The selection is the closest in revenue within the same industry code. When you order, you can swap competitors. Order competitor analysis
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 6 November 2026. Only names are shown.
Shareholders (2025)
- Number of shareholders
- 1 (one owner)
- Largest owner
- 100.0%
- Split
- companies 0% · private persons 100% · foreign 0%
- Owned from the same municipality
- 100%
- Group chain
- Ultimate owner: private person
The company is new in the shareholder register in 2025.
Holds shares in: Fredrikstad Øyelegesenter AS (50%)
Source: the Norwegian Tax Administration's shareholder register as of 2025. Figures may be older than today's ownership. Private persons are not shown by name.
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Is this your company? Suggest changes or add information
Figures last fetched 9 November 2026.
Year by year
Trends appear once there is more than one fiscal year.
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2025 |
|---|---|
| Operating revenue | 1.5 MNOK |
| Operating profit | 0.5 MNOK |
| Profit before tax | 0.5 MNOK |
| Tax expense | 0.1 MNOK |
| Net profit | 0.4 MNOK |
| Financial expenses | 0.0 MNOK |
| Total assets | 1.6 MNOK |
| Current assets | 0.9 MNOK |
| Equity | 0.0 MNOK |
| Retained earnings | 0.0 MNOK |
| Total liabilities | 1.6 MNOK |
| Current liabilities | 1.5 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 9 November 2026, accounts id 6573727.
Further
Similar companies
- Tannlegene Bente og Vegard Berg AS index 44, rank 4,129 · compare
- Fysioklinikken Ragnarock AS index 44, rank 4,130 · compare
- Rena Fysioterapi og Treningssenter AS index 44, rank 4,132 · compare
- Maura Legesenter AS index 44, rank 4,135 · compare
- Tannlege Trine Evjensvold AS index 44, rank 4,136 · compare